Warm Autoimmune Hemolytic Anemia Market to Observe Stunning Growth at a 14.4% CAGR During the Forecast Period (2026-2036) Due to the Emergence of Novel Drug Classes Such as FcRn Inhibitors, BTK Inhibitors, BAFF-R, and Others | DelveInsight

The wAIHA market landscape is undergoing a significant evolution after years of dependence on broad immunosuppressive therapies such as corticosteroids, rituximab, and other nonspecific agents. Current pipeline developments are steering the market toward targeted, mechanism-based immune modulation, with…

Read the full release →

News provided by PR Newswire.